Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enact Holdings, Inc. filings document the formal disclosures of a U.S. private mortgage insurance company. Form 8-K reports furnish quarterly and annual operating results, press releases, and financial supplements covering mortgage insurance performance, capital sufficiency, insurance in force, book value, and related financial measures.
The company's regulatory filings also cover proxy governance, board and stockholder voting matters, executive compensation, capital-return actions, stock repurchase arrangements involving Genworth Financial, and financing agreements such as its revolving credit facility. These records describe Enact's public-company governance, capital structure, liquidity arrangements, and material events tied to its mortgage insurance operations.
Enact Holdings director Dominic James Addesso received a grant of 281 Deferred Stock Units on Common Stock-equivalent terms. These units were awarded at a price of $0.00 per unit and increase his directly held deferred stock units to 9,293.163 units following the transaction.
According to the footnotes, the additional deferred stock units were acquired under the director award agreement through reinvestment of a dividend paid on March 19, 2026 at $0.21 per share. The deferred stock units become payable in shares of Enact Holdings Common Stock one year after termination of his service as a director.
THOMPSON WESTLEY V reported acquisition or exercise transactions in this Form 4 filing.
Enact Holdings director Westley V. Thompson received an automatic grant of 162 Deferred Stock Units on Common Stock-equivalent terms. These units were credited at a price of $0.21 per share under reinvestment terms tied to a dividend paid on March 19, 2026. Following this compensation-related award, Thompson directly holds a total of 30,705.457 Deferred Stock Units, which will be settled in shares of Common Stock one year after his termination of service as a director.
Enact Holdings director Elizabeth H. Mitchell reported an acquisition of 30 Deferred Stock Units linked to Enact common stock. These units were granted at a price of $0.00 per unit and increase her direct deferred stock unit balance to 5,718.256 units after the transaction.
According to accompanying notes, the additional deferred stock units were acquired under the director award agreement’s reinvestment terms from a dividend paid on March 19, 2026 at $0.21 per share. The deferred stock units become payable in shares of common stock one year after her termination of service as a director.
Enact Holdings director Michael A. Bless reported an acquisition of 139 Deferred Stock Units on Enact common stock. The units were added under a director award agreement through reinvestment of a cash dividend paid on March 19, 2026 at $0.21 per share. After this award, Bless holds 26,631.538 Deferred Stock Units, which become payable in Enact common shares one year after his termination of service as a director.
Enact Holdings, Inc. Controller James McMullen reported an open-market sale of 2,500 shares of common stock at $41.64 per share. After this transaction, he directly holds 1,272 Enact Holdings shares. The sale was executed through a series of broker-assisted trades at the same price.
ACT reported a Form 144 disclosing a sale of common stock. The filing shows 678 shares sold on 02/04/2026 by Suzanne Mcmullen for $29,832.00.
The excerpt also lists restricted stock vesting events with amounts and dates: 454 on 02/11/2024, 406 on 02/16/2025, 640 on 02/09/2026, 543 on 02/16/2026, and 457 on 02/21/2026.
Enact Holdings EVP and Chief Risk Officer Michael Derstine reported an open-market sale of 9,000 shares of common stock on March 2, 2026. The weighted average sale price was about $42.213 per share, from individual trades between $42.09 and $42.25. After this sale, he directly holds 39,104 shares.
Enact Holdings, Inc. reported that major shareholder Genworth Holdings, Inc. sold 398,731 shares of Enact common stock on February 27, 2026. The shares were repurchased by Enact under a Share Repurchase Agreement dated February 2, 2026, at a price of $42.1927 per share.
After this transaction, Genworth directly held 114,190,099 Enact shares and remained a controlling shareholder, owning approximately 81% of Enact’s outstanding common stock.
Enact Holdings, Inc. is a leading U.S. private mortgage insurer focused on low down payment home loans, operating in all 50 states and the District of Columbia. Its insurance helps lenders sell mortgages into the secondary market, including to Fannie Mae and Freddie Mac, by covering a portion of unpaid principal when borrowers default.
For the year ended December 31, 2025, Enact wrote new insurance on $51.5 billion of mortgages and reported net income of $674 million and adjusted operating income of $688 million. The insured portfolio has a weighted average loan-to-value of 93% and a weighted average FICO score of 746, reflecting a focus on higher-quality borrowers despite high LTVs.
The company uses an extensive credit risk transfer program, including excess-of-loss reinsurance and mortgage insurance-linked notes, to shift part of its mortgage credit exposure to reinsurers and capital markets while also supporting capital requirements under PMIERs. As of December 31, 2025, Enact reported estimated PMIERs available assets of $5,015 million against net required assets of $3,096 million, a 162% sufficiency ratio. Its investment portfolio totaled $6.1 billion of predominantly investment-grade fixed maturities plus $582 million in cash, and it employed 419 full-time staff, largely in Raleigh, North Carolina and field underwriting and sales roles.